Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPediatrics Physician in San Francisco, CA
NPI: 1023128592HQ Phone
Get M.D. Jeffrey's Phone Numberphone_androidMobile
Get M.D. Jeffrey's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1996 - 2022
CA State Medical License
University of California (San Francisco) School of Medicine
Fellowship • Allergy and Immunology
1997 - 1999
University of Florida
Ph.D. • Neuroscience
Until 1992
B.S. • Neuropharmacology
Until 1986
UCSF School of Medicine
medschool.ucsf.edu
Post-Doctoral Fellowship • 1998 - 2001
1998 - 2001
Residency • Pediatrics
1994 - 1997
University Of Florida College Of Medicine
med.ufl.edu
Medical School
Until 1994
Multiparameter evaluation of human thymic function: interpretations and caveats.
Authors: Harris, Jeffrey M, Hazenberg, Mette D, Poulin, Jean-François, Higuera-Alhino, Dana, Schmidt, Diane, Gotway, Michael, McCune, Joseph M
Journal: Clin Immunol
Authors: Scheerens, H, Malong, A, Bassett, K, Boyd, Z, Gupta, V, Harris, J, Mesick, C, Simnett, S, Stevens, H, Gilbert, H, Risser, P, Kalamegham, R, Jordan, J, Engel, J, Chen, S, Essioux, L, Williams, J A
Journal: Clin Transl Sci
Publication Date: 2017-02-27
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.
Authors: Harris, Jeffrey M, Cabanski, Christopher R, Scheerens, Heleen, Samineni, Divya, Bradley, Mary S, Cochran, Colette, Staubach, Petra, Metz, Martin, Sussman, Gordon, Maurer, Marcus
Journal: J Allergy Clin Immunol
Publication Date: 2016-07-19
Lead Sponsor: Genentech, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Quilizumab
Lead Sponsor: Genentech, Inc.
Intervention / Treatment: DRUG: placebo, DRUG: MEMP1972A